«Tangier Disease

Below is an extended Tangier Disease patents listing. Click here to return to the Tangier Disease main in depth entry.

Patents :
US Patent No.	Title
7094882	Growth factor which acts through erb b-4 rtk
7166700	PRO703 Polypeptides
7169912	PRO1017 nucleic acids
7175999	Polynucleotide and polypeptide fat metabolism regulators and uses thereof
7189529	PRO792 nucleic acids
7193050	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7195760	Anti-pro363 antibodies
7196108	Bicyclic heterocycles for the treatment of diabetes and other diseases
7196165	PRO363 polypeptides
7196176	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7202338	PRO731 polypeptides
7166584	Cholesterol transport gene
7163701	Controlled release microencapsulated NGF formulation
7157259	Murine lecithin-cholesterol acyltransferase protein
7098036	Antibodies to lipoproteins and apolipoproteins and methods of use thereof
7101838	Method to prevent accelerated atherosclerosis using (sRAGE) soluble receptor for advanced glycation endproducts
7102000	Heterocyclic amide derivatives for the treatment of diabetes and other diseases
7105640	Anti-pro792 antibodies
7112657	PRO697 polypeptides
7115653	Small organic molecule regulators of cell proliferation
7122375	PRO274 nucleic acids
7125856	Angiogenic growth factors for treatment of peripheral neuropathy
7132283	PRO273 polypeptides
7153875	Heterocyclic derivatives for the treatment of cancer and other proliferative diseases
7208575	PRO531 polypeptides
7211563	Protein disulfide isomerase and ABC transporter homologous proteins involved in the regulation of energy homeostasis
7303895	Choline transport like (CTL) membrane proteins involved in choline transport
7304029	Neuroprotective effect of growth hormone
7351535	Compositions and methods for increasing cholesterol efflux and raising HDL using ATP binding cassette transporter protein ABC1
7371836	PRO526 nucleic acids
7378274	Regulatory nucleic acid for the ABC1 gene, molecules modifying its activity and therapeutic uses
7378396	Therapeutic agents and methods for cardiovascular disease
7378492	CD40-related receptor that binds CD40L
7387895	Monoclonal antibody specific for PPAR gamma, hydridoma cell line producing the same, and method for detecting regulator related to diseases, including inflammation, cancer and metabolic diseases, using the same
7401026	Genetic profiling and banking system and method
7404952	Protein disulfide isomerase and ABC transporter homologous proteins involved in the regulation of energy homeostasis
7297515	Zinc finger proteins
7294700	Anti-PRO846 antibodies
7285623	PRO337 polypeptides
7214656	PRO792 polypeptides
7217785	Cysteine-containing peptides having antioxidant properties
7220835	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7226940	Substituted heterocycles for the treatment of diabetes and other diseases
7229816	Sitosterolemia susceptibility gene (SSG) polypeptides
7232667	Keratinocyte growth factor-2 polynucleotides
7265131	Isoquinolinone derivatives and their use as therapeutic agents
7265139	RXR activating molecules
7276593	Proteins and nucleic acids encoding same
7279553	PRO1083 polypeptides
7416853	Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.